Latest posts tagged with #OPAT on Bluesky
Symposium 5 | Optimising Antimicrobials in Different Settings - From outpatient therapy to ICU and bone infections, this session will discuss proactive strategies for optimal antimicrobial use.
#Antimicrobials2026 #ICU #InfectiousDiseases @trishapeel.bsky.social #BJI #OPAT #HITH #idksy #medsky #ams
Plenary 1 is underway at #Antimicrobials2026: AMS in the Home.
As care increasingly shifts beyond hospital walls, stewardship must follow. Governance, oversight and patient safety don’t stop at discharge, they evolve.
#AMS #AMR #InfectiousDiseases #OPAT #HITH #Idsky #medsky #ASA
🩺🦠How well do #OPAT antimicrobials really hit PK-PD targets? Our UK prospective study shows good attainment across agents, while demonstrating the feasibility of #TDM to support #precisiondosing in outpatient infection care doi.org/10.1093/jac/... @tmrawson.bsky.social @mgilchrist123.bsky.social
Out now in @cidjournal.bsky.social my first ever investigator-initiated funded study - A pilot trial evaluating IV Ensure, a remote therapeutic monitoring device in OPAT!
#IDSky #OPAT
Open access thanks to @ou.edu libraries so check it out!
Key highlights in 🧵
academic.oup.com/cid/advance-...
#idweek2025 #idsky #OPAT Dr Childs-Kean
@corevalues5.bsky.social well received:
patient perspective from urban area Germany 2/ physician anxiety, pt w/information overload
pmc.ncbi.nlm.nih.gov/articles/PMC...
#idweek2025 #idsky #OPAT Dr Childs-Kean
@corevalues5.bsky.social
patient perspective from urban area Germany 1/
BMC Health Serv Res
2024 Apr 29;24(1):544.
#idweek2025 #idsky #OPAT Dr Childs-Kean @corevalues5.bsky.social 1/ average 27min/week outside of clinic non-billiable care: we need ways to fund this time @cidjournal.bsky.social
2024 May 14;79(2):348–350. doi: 10.1093/cid/ciae262
🩺 Can reducing the frequency of monitoring safely lessen the burden on OPAT teams and patients?
In 420 patients, only 2% had lab abnormalities linked to readmission or treatment change.
academic.oup.com/ofid/article...
#OPAT #AntimicrobialStewardship #IDPharmacy
📢 Join us for an HMS webinar:
"Are Midlines Safe for Vancomycin in OPAT?"
🗓️ Wednesday, Oct 8, 2025
🕒 3–4 PM EST
🎙️ Featuring Dr. David Paje & Dr. Anurag Malani
🏫 CME & CE available!
🔗 Register now: umich.zoom.us/meeting/regi...
#OPAT #HospitalMedicine #Vancomycin #PatientSafety
1➡️Une recommandation concernant l’administration des antibiotiques par voie intraveineuse en perfusion prolongée et continue en pédiatrie.
www.sciencedirect.com/science/arti...
#IDSky #IDSkyFr #Guidelines #Antibiotics #ContinuousInfusion #OPAT #Pediatrics
Long-acting lipoglycopeptides can provide a convenient alternative to daily antibiotic infusions for enterococcal endocarditis.
doi.org/10.1093/ofid...
PraediAlert can help you monitor OPAT patients to ensure proper follow up care.
#PraediAlert #OPAT #endocarditis
Infusión de vancomicina en pacientes que egresan con catéter de vía central para terapia antimicrobiana parenteral ambulatoria se asocia con riesgo 5 veces mayor de complicaciones mayores y retiro prematuro del catéter #OPAT #vancomicin jamanetwork.com/journals/jam...
🚨 Are midline catheters a safe choice for vancomycin OPAT?
Despite guideline caution, evidence is limited. Using @HMS_MI data, we explored complication risks in hospitalized patients receiving OPAT—with & without vancomycin.
Clinical dogma, meet data. 💉📊 #PatientSafety #OPAT
Attend FIS International 2025 for sessions including #Decontamination from bench
to bedside, Controversies in #InfectiousDiseaseManagement, #OPAT and much more 👉 fitwise.eventsair.com/fis2025/prog...
@hisinfection.bsky.social @biainfection.bsky.social #FIS25 #IDSky
Delighted with our “ CEO best patient compliment of the year” award 🫶🏼 @whithealth.bsky.social #OPAT #Sendingpatientshome
1➡️Une recommandation portant sur l’administration intraveineuse d'antibiotiques par perfusion prolongée et continue dans un contexte pédiatrique.
www.sciencedirect.com/science/arti...
#IDSky #Antibiotics #ContinuousInfusion #OPAT #Pediatrics
when trying to coordinate with skilled nursing facilities
One of our key results? "The estimated cost avoided per 100 patient-days was $376,400 or approximately $5,430,197 per month."
4/4
#OPAT #infectiousdiseases #medsky #healthcare #SNF #OFID #savings #affordable #research #publication
A journal article title reading: Inpatient Cost Avoidance and Uncompensated Labor Associated With Different Outpatient Parenteral Antimicrobial Therapy Care Models
Extremely proud to share that our study on the costs and savings associated with outpatient parenteral antimicrobial therapy (i.e. discharging patients with IV antibiotics, #OPAT) has finally been published in @ofidjournal.bsky.social !
Find it here:
academic.oup.com/ofid/article...
1/4
#OPAT is a great step forward in patient care, and should go hand in hand with #AMSsky teams.
Without integration, #OPAT might entail delayed oral switch and de-escalation, or longer treatments.
In this multicenter survey, only 56% had integrated AMS & OPAT programs. Let's work together! #IDSky
This is helpful, opening up a new drug (tigecycline) to be put into elastomeric devices for patients that need #OPAT
#IDSky #ClinMicro #AMR
@jac-amr.bsky.social
academic.oup.com/jac...
[Publication] The article "Intravenous administration of antibiotics by prolonged and continuous perfusion in a pediatric context" is now available.
www.sciencedirect.com/science/arti...
#IDsky #Guidelines #Antibiotics #ContinuousInfusion #OPAT #Pediatrics
